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Abstract
Purpose Given that the relationship between vitamin D status and metabolic diseases such as obesity and type 2 diabetes (T2D)
remains unclear, this review will focus on the genetic associations, which are less prone to confounding, between vitamin D-
related single nucleotide polymorphisms (SNPs) and metabolic diseases.
Methods A literature search of relevant articles was performed on PubMed up to December 2019. Those articles that had
examined the association of vitamin D-related SNPs with obesity and/or T2D were included. Two reviewers independently
evaluated the eligibility for the inclusion criteria and extracted the data. In total, 73 articles were included in this review.
Results There is a lack of research focusing on the association of vitamin D synthesis-related genes with obesity and T2D;
however, the limited available research, although inconsistent, is suggestive of a protective effect on T2D risk. While there are
several studies that investigated the vitamin D metabolism-related SNPs, the research focusing on vitamin D activation, catab-
olism and transport genes is limited. Studies on CYP27B1, CYP24A1 and GC genes demonstrated a lack of association with
obesity and T2D in Europeans; however, significant associations with T2D were found in South Asians. VDR gene SNPs have
been extensively researched; in particular, the focus has been mainly on BsmI (rs1544410), TaqI (rs731236), ApaI (rs7975232)
and FokI (rs2228570) SNPs. Even though the association between VDR SNPs and metabolic diseases remain inconsistent, some
positive associations showing potential effects on obesity and T2D in specific ethnic groups were identified.
Conclusions Overall, this literature review suggests that ethnic-specific genetic associations are involved. Further research
utilizing large studies is necessary to better understand these ethnic-specific genetic associations between vitamin D deficiency
and metabolic diseases.
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25(OH)D 25 hydroxyvitamin D












1 Hugh Sinclair Unit of Human Nutrition, Department of Food and
Nutritional Sciences, University of Reading, PO Box 226,
Whiteknights, Reading RG6 6AP, UK
2 Department of Food Science and Nutrition, Faculty of Health
Sciences, The Public Authority for Applied Education and Training,
P.O. Box 14281, AlFaiha 72853, Kuwait
3 Department of Nutrition, Faculty of Health Sciences, University
Alma Ata, Yogyakarta 55183, Indonesia
4 Postgraduate Biomedical Science Department, Faculty of Medicine,
Andalas University, West Sumatra 25172, Indonesia
5 Avinashilingam Institute for Home Science and Higher Education for
Women, Coimbatore, Tamil Nadu, India




DBP Vitamin D binding protein
VDR Vitamin D receptor
GWAS Genome wide association studies
RXR Retinoid X receptor
VDRE Vitamin D receptor elements
BMI Body mass index




SSFT Sum of skin fold thickness
TBF Total body fat
VF Visceral fat
BM Body mass
WHR Waist hip ratio
PBF Percent body fat
PTF Percent total fat
PVD Percent visceral deposit
TSFT Triceps skinfold thickness
BG Blood glucose
ISI Insulin secretion index
FPG Fasting plasma glucose
HbA1c Glycated haemoglobin
FSG Fasting serum glucose
Introduction
Vitamin D is a fat-soluble vitamin and a secosteroid
prohormone that plays a crucial role in bone mineralization
through the absorption and regulation of calcium and phos-
phate levels [1]. The vitamin D endocrine system regulates
calciumhomoeostasis and a range of physiological functions
such as cell growth, proliferation, differentiation, immune
function, inflammation, and apoptosis [2].A broad spectrum
of diseases has been related to vitamin D deficiency and re-
search, to date, suggests that vitaminDdeficiency is amarker
of ill health with effective connection to all-cause mortality,
obesity, diabetes, cardiovascular risk, hypertension,
dyslipidaemia, multiple sclerosis, Alzheimer, and some
types of cancer [3–7]. However, causality is yet to be proven
for any disease that is associated with vitamin D deficiency.
Vitamin D3 (cholecalciferol) is the natural form of vi-
tamin D and the body can synthesise it in the skin in
response to the sunlight exposure. Ultraviolet-B (UVB)
(290–315 nm wavelength) skin irradiation initiates the
photochemical conversion of 7DHC (provitamin D3) to
previtamin D3 by breaking the 9,10 carbon-carbon bond,
which is then quickly thermally isomerized to vitamin D3.
Diet is another source of vitamin D3, which can be ob-
tained from animal foods such as oily fish, egg yolk, liver,
bu t t e r , fo r t i f i ed mi lk and cheese . Vi tamin D2
(ergocalciferol) originates from conversion of a plant ste-
rol, ergosterol, and is solely obtained from the diet which
includes plant-sourced foods such as yeast and mush-
rooms [8, 9]. Vitamin D3 has a superior bioavailability
than vitamin D2; nonetheless, they both go through the
same metabolic pathway to produce the active hormonal
forms [4, 10]. Vitamin D is biologically inert and has to
undergo hydroxylation twice before it can perform its
physiological functions. Vitamin D binding protein
(DBP/GC) is the key transport protein, which binds over
85% of the circulating 25(OH)D and vitamin D metabo-
lites, and it transports these metabolites to target cells. In
the liver, vitamin D (cholecalciferol and ergocalciferol) is
converted by the enzyme 25-hydroxylase (CYP2R1) into
25-hydroxyvitamin D [25(OH)D], also known as
calcidiol, which is the primary circulating form of vitamin
D. Subsequently, the kidney, acting as an endocrine
gland, converts 25(OH)D by the action of the enzyme
1α-hydroxylase (CYB27B1) to the active hormonal form
1α, 25-dihydroxyvitamin D [1,25(OH)2D], also known as
calcitriol, which then binds to VDR and regulates calcium
homeostasis and bone metabolism (Fig. 1). The VDR, a
member of the nuclear receptor family, is a receptor spe-
cific to vitamin D through which vitamin D exerts its
function, and it has been discovered in a multitude of cell
membranes of tissues that have no musculoskeletal func-
tion; this implies the involvement of vitamin D in various
extra-skeletal biological functions [3, 4, 6].
Heritability of vitamin D deficiency has been reported
by twin and family studies to range between 20–85%
[11]. Although there is a great variation in the estimation
of the heritability results, they do show that genetic fac-
tors play a role in circulating serum 25(OH)D levels.
Candidate gene studies have reported several single nu-
cleotide polymorphisms (SNPs) related to serum
25(OH)D levels mainly with genes that are involved in
synthesis and metabolism of vitamin D such as DHCR7,
CYP2R1, CYP27B1, CYP24A1, DBP/GC, VDR [12].
Genome wide association studies (GWAS) have con-
firmed the association between genetic polymorphisms
in the genes such as GC , DHCR7 , CYP2R1 and
CYP24A1 and 25(OH)D concentrations [11].
There exists a plethora of studies that have reported
association of genetic variants with low vitamin D levels
and a wide spectrum of associated diseases [13–16]. This
article aims to evaluate the results of the associations be-
tween vitamin D-related genetic variants and metabolic
diseases such as obesity and type 2 diabetes (T2D).
Understanding the possible underlying genetic factors of
vitamin D metabolism will lead to an increased under-
standing of the biological mechanisms underlying vitamin
D deficiency and its effects on metabolic diseases.
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Methods and materials
Study identification
To review published research articles relevant to the topic, a
literature search of PubMed (National Library of Medicine)
https://www.ncbi.nlm.nih.gov/pubmed/ was performed up to
December 2019. The following key terms were used to search
for research articles: “vitamin D genetics and diabetes” (n =
543), “vitamin D genetics and obesity” (n = 202), “vitamin D
gene polymorphisms and diabetes” (n = 308), “vitamin D
gene polymorphisms and obesity” (n = 85), “Genetic
variants of vitamin D and diabetes” (n = 79), “Genetic
variants of vitamin D and obesity” (n = 31), “vitamin D
Fig. 1 Vitamin D synthesis and
metabolism. Upon exposure to
Ultraviolet-B (290–315 nm
wavelength) skin irradiation, 7-
dehydrocholesterol produces pre-
vitamin D3, by breaking the C (9–
10) bond at the B ring, which then
undergoes a thermally induced
rearrangement to form vitamin
D3. Vitamin D can also enter the
body from dietary sources in two
forms: vitamin D3
(cholecalciferol) from fish, eggs,
fortified milk and supplements
and vitamin D2 (ergocalciferol)
from mushrooms and yeast. Once
transported to the liver, vitamin D
is hydroxylated to 25(OH)D
(calcidiol) by 25-hydroxylase en-
zymes (CYP2R1& CYP27A1). In
the kidneys, 25(OH)D is further
hydroxylated by two enzymes to
activate or inactivate vitamin D.
For activation, the 1α-
hydroxylase enzyme (CYP27B1)
converts 25(OH)D to 1α,25-
dihydroxyvitamin D (calcitriol),
which is transported by vitamin D
binding protein (DBP/GC).
Finally, Calcitriol binds to vita-
min D receptor (VDR) to perform
its biological function. For inacti-
vation, the 24-hydroxylase en-
zyme (CYP24A1) catabolizes
25(OH)D to 24,25-dihydroxy vi-
tamin D. Control of metabolism
of vitamin D is exerted primarily
by biliary excretion
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SNPs and diabetes” (n = 150), “vitamin D SNPs and obesity”
(n = 57). As a result of all the search combinations, a total of
1,455 articles were obtained. Citations from relevant papers
and review papers were examined to identify additional
relevant articles for inclusion.
Study selection
Any study that was published in PubMed and written in
English was included. Only genetic association studies exam-
ining the association of vitamin D-related SNPs with diabetes
and/or obesity were included. Studies were excluded if they
were (1) animal studies; (2) studies in pregnant women; (3)
studies on humans identifiedwith disease other thanmetabolic
diseases; (4) randomized controlled trials; (5) gene-vitamin D
interaction studies, (6) haplotype studies, (7) studies with out-
come as serum 25(OH)D, bone disease, metabolic syndrome,
type 1 diabetes, diabetic complications or any other disease
except for obesity and T2D.
The article titles were reviewed to eliminate duplication
and relevant papers were chosen (n = 112). Abstracts of the
chosen articles were read to further determine their relevance
to our topic. After reading the full text of these papers, 73
articles were considered relevant and were included to extract
the data for this review (Fig. 2).
Data extraction
The studies were identified by a single investigator (BA), and
the following data were double-extracted independently by
two reviewers (VK and AS): first author, publication year,
location or ethnicity of participants, sample size, mean age,
study design, SNP position, name and reference SNP (rs) ID,
genotype and allele distribution for vitamin D. Corresponding
authors were contacted to provide any additional information
where needed.
This review will look at the genes that function upstream
and influence 25(OH)D synthesis (DHCR7, CYP2R1) and the
genes that function downstream and play a role in 25(OH)D
metabolism (CYP24A1, CYP27B1, GC/DBP, VDR) (Fig. 1).
The following sections will focus on the SNPs in the vitamin
D pathway-related genes and their associations with obesity
traits and T2D.
Vitamin D synthesis genes
Despite several studies that have examined the association
between vitamin D deficiency and metabolic diseases
[13–16], the literature is remarkably scarce in studies investi-
gating the association of genes involved in the synthesis of
25(OH)D with metabolic diseases such as obesity and T2D.
7-Dehydrocholesterol Reductase (DHCR7)
7-Dehydrocholesterol reductase enzyme is encoded by the
DHCR7 gene and is located on chromosome 11q13.4. The
main function of DHCR7 is to convert 7DHC to cholesterol
[12]. 7DHC is a substrate of the enzyme DHCR7 and is the
precursor of vitamin D (specifically vitamin D3). The conver-
sion of 7DHC to vitamin D3 in the skin is facilitated by expo-
sure to UVB light from the sun which causes the cleavage of
the C (9–10) bond in 7DHC to form vitamin D3 [17]. The
production of cholesterol from 7DHC in the skin reduces the
availability of 7DHC for vitamin D synthesis, which limits
vitamin D production [18].
Cytochrome P450 Family 2 Subfamily R member 1 /
25-Hydroxylase (CYP2R1)
The CYP2R1 gene is located on chromosome 11q15.2.
CYP2R1 encodes 25-hydroxylase enzyme in the liver, which
Total article hits of key term search = 1,455
Abstracts read and evaluated = 112
Articles included in this review = 73
“T2D**, 45 + Obesity, 24 + Both, 4”
Irrelevant* and duplicate articles = 1,343
Excluded articles = 39
Outcome, 25(OH)D = 17
Studies that were not in English = 9
Gene-vitamin D interaction studies = 4
Outcome, MetS** = 4
Haplotypes = 2
Gestational diabetes = 2
Randomized controlled trial = 1
Fig. 2 Flow chart describing the
literature search and the steps
involved in selecting the articles.
*Irrelevant articles are those that
did not meet the inclusion criteria.
**MetS: Metabolic Syndrome;
T2D: Type 2 diabetes
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is the main enzyme responsible for the conversion of vitamin
D3 and vitamin D2 to the main circulating form of vitamin D
[25(OH)D] [19].
Obesity
Two cross-sectional studies investigated SNPs in the vitamin
D synthesis-related genes; DHCR7 SNP was examined in a
small study (n = 323) of African ethnicity and CYP2R1 SNP
was studied in nearly 7,000 Chinese women [20, 21]. Nominal
significant associations were reported with obesity traits in the
Chinese study for CYP2R1 rs10832313 polymorphism; how-
ever, this did not remain significant after correction for multi-
ple testing [20] and no significant associations were reported
for DHCR7 SNP rs12785878 in the African population [21].
There are two notable large studies by Vimaleswaran et al.
that examined SNPs from the DHCR7 and CYP2R1 vitamin
D synthesis-related genes in relation to obesity using data
from multiple Caucasian cohorts [22, 23]. One study was a
bi-directional Mendelian Randomization study (n = 42,024)
which showed that 10% genetically higher BMI was associ-
ated with 4.2% lower concentrations of 25(OH)D but no sig-
nificant effect of vitamin D allelic scores on obesity was re-
ported [22]. The other study was a genetic association analysis
that analyzed 5,224 participants from the 1958 British birth
cohort (1958BC) and 123,865 individuals from the GIANT
(Genetic Investigation of Anthropometric Traits) consortium.
None of the vitamin D synthesis SNPs was significantly asso-
ciated with obesity traits [23]. Although the number of studies
that investigated the association between vitamin D synthesis
genes and obesity were small, the lack of association found in
the two very large meta-analysis studies [22, 23] does suggest
that the vitamin D synthesis-related gene polymorphisms may
not be a contributing factor to the development of obesity.
However, further studies with large number of samples are
required to confirm the role of these SNPs in obesity and its
related traits.
Type 2 diabetes
Studies using vitamin D synthesis-related gene polymor-
phisms suggest an association with low serum 25(OH)D con-
centrations and increased diabetes risk [24]. A recent prospec-
tive observational study in Italians (n = 2,163) demonstrated
an association between DHCR7 (rs12785878) and 25(OH)D
concentrations (P = 1 × 10− 4) in T2D patients [25].
Furthermore, in a recent large Mendelian Randomization
meta-analysis of 10 studies from European and Chinese pop-
ulations (n = 58,312 cases and 370,000 controls), the allelic
score of two SNPs from the vitaminD synthesis-related genes,
DHCR7 (rs12785878) and CYP2R1 (rs10741657), were
shown to be significantly associated with lower risk of T2D
(P = .01), where a 25 nmol/l higher 25(OH)D concentration
was associated with a 14% lower risk of diabetes [26]. A
Mendelian Randomization analysis in 96,423 Danish individ-
uals examined four genetic polymorphisms in theDHCR7 and
CYP2R1 genes in relation to T2D [24], where the DHCR7
allele score (rs11234027 + rs7944926) showed a significant
association with increased risk of T2D (P for trend = 0.04);
but there were no significant associations between CYP2R1
SNPs or allele scores and risk of diabetes [24]. In the Chinese
Han population (n = 794), the ‘G’ allele carriers of the
CYP2R1 SNPs, rs10766197 and rs1993116, had 1.64 and
1.76 times increased risk of developing T2D compared with
‘AA’ homozygotes, respectively (P = .024 and P = .048, re-
spectively) [27]. However, the studies in 53,088 Germans
and 4,877 Norwegians failed to show an association of
SNPs in the DHCR7 (rs12785878, rs3829251, rs3794060)
and CYP2R1 (rs10741657) genes with T2D [28, 29].
Although there is inconsistency in the results across various
studies, a recent large Mendelian Randomization meta-
analysis (n = 428,312) [26] has provided evidence that genet-
ically instrumented higher 25(OH)D has a protective effect
against diabetes risk. However, more studies are needed to
confirm this finding and understand the functional signifi-
cance of vitamin D synthesis-related genes in T2D.
Vitamin D metabolism genes
Several studies have examined the association of vitamin D
metabolism-related SNPs with metabolic diseases; however,
majority of the studies have been restricted to the VDR SNPs
and only a few studies have investigated the association of
genes involved in activation, catabolism and transport of
25(OH)D with metabolic diseases. Hence, VDR–related
SNPs are discussed in a separate section.
I. Activation, Catabolism, and Transport Genes
Cytochrome P450 Family 27 Subfamily B member 1 /
1α-Hydroxylase (CYP27B1)
The CYP27B1 gene is located on chromosome 12q14.1. The
activating enzyme 1α-hydroxylase is encoded by the
CYP27B1 gene in the kidney where 25(OH)D is converted
to the active 1α,25(OH)2Dwhich binds to the VDR to perform
its biological functions [30, 31].
Cytochrome P450 Family 24 Subfamily A member 1 /
24-Hydroxylase (CYP24A1)
The CYP24A1 gene, which is located on chromosome
20q13.2, codes for the vitamin D inactivating enzyme 24-
hydroxlase. This enzyme controls the levels of vitamin D in
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blood serum by breaking down the active form to biliary ex-
cretory products and by reducing intestinal absorption of cal-
cium and phosphate. Mutations in the gene have been shown
to result in hypercalcemia and nephrolithiasis [32, 33].
Vitamin D Binding Protein (DBP) / Group-Specific Component
(GC).
TheDBP/GC gene is located on chromosome 4q13.3. TheGC
gene encodes for vitamin D binding protein (DBP), which is a
glycoprotein secreted by the liver, that binds to vitamin D and
its metabolites from the gut and skin and transports them to
target tissues and organs and, hence, factors affecting DBP
levels can also affect vitamin D concentrations. Nearly 85%
of serum 25(OH)D is bound to DBP and the remainder 15%
binds to albumin. Approximate ly 0.4% of to ta l
1α,25(OH)2D3 and 0.03% of total 25(OH)D3 exist in the un-
bound, free form in the serum of healthy individuals (exclud-
ing pregnant women) [34, 35].
Obesity
To date, there has been only one study in Europeans (n =
5,224) [23] that has investigated the association of CYP27B1
SNPs, rs1048691 and rs10877012, with obesity and this study
did not find any significant association of these SNPs with
obesity-related outcomes. The same study in 5,224
Europeans also failed to show an association of 22
CYP24A1 SNPs with obesity [23]. This is in line with another
study in up to 700 Chinese women [20], which also did not
show a significant association of the CYP24A1 SNP
rs2248359 with obesity traits after correction for multiple test-
ing. For theGC gene, while a study in 5,224 participants from
the 1958 British Birth Cohort failed to show an association of
the 13 SNPs in the GC gene with obesity outcomes [23],
studies in Caucasian nuclear families [36] (n = 1,837),
Bahraini population [37] (n = 406) and African population
[21] (n = 323) showed significant associations of SNPs in
the GC gene with obesity-related outcomes. Based on the
Quantitative Transmission Disequilibrium Test in the
Caucasian nuclear family study, it was shown that the GC
SNP rs17467825 increased percent fat mass (PFM) by 1.42
times and the haplotype ‘GAA’ in the GC gene increased
PFM by 1.19 times [36]. In the African population, the ‘TT’
genotype of the GC SNP rs2298849 was associated with 1.76
times increased risk of overweight [21]. Furthermore, the vi-
tamin Dmetabolism-related genes were also analysed as a risk
score in a Mendelian Randomization study in 42,024
Caucasians and there was no significant causal effect of the
vitamin D metabolism-risk score on obesity [22].
Only a few studies have focused on the genes involved in
activation, catabolism and transport of 25OHD of which there
has been only one study on activation gene CYP27B1 in
relation to obesity [23]. Three studies have examined the ca-
tabolism gene CYP24A1 SNPs; however, none of them
showed a significant association with obesity traits [20, 22,
23]. Five studies included SNPs from the transport gene GC
[21–23, 36, 37], where only three studies showed significant
associations with obesity [21, 36, 37]. Given that majority of
the studies failed to find an association of these SNPs with
obesity outcomes, it is quite unlikely for the SNPs in the
CYP27B1, CYP24A1 and GC to have a significant functional
role in obesity-related metabolic pathways.
Type 2 diabetes
There have been only two studies [28, 38] that examined
SNPs from vitamin D activating CYP27B1 gene in relation
to T2D and both the studies, the prospective case-cohort study
in 53,088 Germans [28] and a cross-sectional study in 522
individuals from a Polish population [38], failed to show an
association of CYP27B1 SNPs, rs10877012 and rs184712,
with T2D, respectively. Five studies have explored the asso-
ciation of SNPs in vitamin D catabolism CYP24A1 gene with
T2D [26, 28, 29, 39, 40]. Two Chinese case-control family-
based studies (n = 1,560 & n = 1,556) examined CYP24A1
SNPs rs2248359 and rs4809957 [39, 40]; while the study in
1,556 individuals showed no association of the SNP
rs4809957 with T2D [40], the study in 1,560 individuals dem-
onstrated an association of the SNP rs2248359 with T2D in
women (P = .036) but not inmen (P = .816) [39]. It was shown
that the ‘T’ allele of the SNP rs2248359 was transmitted 1.39
times more in offspring of T2D participant compared to non-
T2D participant (P = .035) suggesting that ‘T’ allele might be
a risk factor for T2D.
Despite large sample size, three studies, one in Germans
(n = 53,088) [28], the other in Norwegians (n = 4,877) [29],
and a study in Chinese (n = 5,566) [26] failed to find an asso-
ciation between CYP24A1 SNP rs6013897 and T2D. In the
vitamin D transport gene, GC, significant associations were
reported in Asians [41–43] but not in European populations
such as Germans, Polish and Norwegians [26, 28, 29, 44].
However, a recent prospective observational study in
Europeans recruited from Italian outpatient clinics did provide
an evidence of association between GC (rs4588) and
25(OH)D concentrations (P = 1 × 10− 6) in T2D patients [25].
The GC SNPs, rs7041 (codon 416) and rs4588 (codon 420),
showed a significant association with T2D in a Bangladeshi
population (n = 211) [42]. The participants with Glu/Glu at
codon 416 had 2.87 times increased risk of T2D and the par-
ticipants with Lys/Lys genotype at codon 420 had 8.9 times
increased risk of T2D. Furthermore, the combined allele score
of these two SNPs, rs7041 and rs4588, was significantly as-
sociated with T2D in a case-control study in a Pakistani pop-
ulation (n = 330) [41]. In a meta-analysis of studies of
Caucasians and Asians, there was no association in the overall
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analysis of SNPs at codon 416 and codon 420 with the risk of
T2D, however, after stratification based on ethnicity, a signif-
icant association was found in Asians at codon 420, where the
allele ‘Lys’ had a 1.49 times increased risk of T2D. In addi-
tion, a 1.36 times increased T2D risk was observed for those
with ‘Asp/Asp’ genotype at codon 416 compared to those
with ‘Glu/Asp’ and ‘Glu/Glu’ genotypes [43].
To date, most of the large studies failed to demonstrate a
significant association of the SNPs in the CYP27B1 and
CYP24A1 genes with T2D suggesting that these genes are
unlikely to play a potential role in the pathogenesis of T2D.
However, based on the published studies, genetic variants in
GC genemay have an impact on T2D amongAsians but not in
Europeans, which could be due to the existence of genetic
heterogeneity across the two ethnicities. The possible mecha-
nism of action of GC in T2D could be mediated through the
regulation of plasma calcium levels, which is known to regu-
late insulin synthesis and secretion, and through a direct action
on pancreatic beta-cell function [45].
II. The Vitamin D Receptor (VDR)
The VDR gene is located on chromosome 12q13.11.
Vitamin D receptor, encoded by VDR gene, is a mem-
ber of the nuclear receptor of transcription factors. The
secosteroid 1α,25(OH)2D3, a natural ligand to VDR, en-
ters the target cell and binds to its receptor. The
1α,25(OH)2D3-VDR complex heterodimerizes with the
retinoid X receptor (RXR) and binds to the vitamin D
response element (VDRE), a sequence of DNA nucleo-
tides in the promoter region of the vitamin D regulated
genes . The VDR/RXR-VDRE complex at t rac ts
coactivators and gene transcription is initiated to pro-
duce mRNA, which is then translated to the correspond-
ing protein [46–48]. The VDR gene is predominantly
expressed in kidneys, bones and the intestinal tract for
bone homeostasis but further expression has been dis-
covered in almost all human tissues and organs includ-
ing adipose tissue and cells involved in the regulation
of glucose metabolism, such as muscle and pancreatic
cells [49]. Several functional VDR SNPs are known:
BsmI, ApaI, Tru9I in intron 8, TaqI in exon 9 and
FokI in exon 2. These genetic variants are named after
their restriction enzyme sites [49]. Another VDR SNP is
Cdx2, which is found in the promoter region [3]. Some
of the SNPs in the VDR are restriction fragment length
polymorphisms such as BsmI, ApaI and TaqI. VDR
SNPs are closely linked to a microsatellite poly A re-
peat of variable length in the 3´UTR region which is
thought to affect VDR translation and may affect mRNA
stability [3, 50]. VDR SNPs such as BsmI, ApaI and
TaqI and FokI are the most commonly studied genetic
variants in association with non-skeletal outcomes [51].
Genetic variants in the VDR gene have also shown to
contribute to the genetic susceptibility of T2D by mod-
ulating insulin secretion and affecting cellular insulin
sensitivity [45]. Allelic differences in the VDR gene
have also shown to be possible contributors to obesity
through modulating adipocyte function and affecting ad-
ipocyte inflammation [45, 51, 52].
Obesity
BsmI SNP rs1544410 Thirteen studies have examined the as-
sociation between the VDR BsmI SNP and obesity-related
traits (Table 1), of which nine have reported a significant
association in the Arab, Brazilian, Polish, French, Swedish,
and Vietnamese populations (n = 140–891) [53–61]. In the
Arab population, associations have been consistent in four
studies (n = 198 – n = 891) [53–55, 60] suggesting that the
presence of BsmI risk allele could be a risk factor for obesity
in this ethnic group. Nevertheless, the sample sizes were rel-
atively small; hence, larger studies are required in this popu-
lation to confirm the risk of BsmI polymorphism on obesity.
ApaI SNP rs7975232 Twelve Studies have investigated the as-
sociation between the VDR ApaI polymorphism and obesity
traits (Table 1) and four of them have reported significant asso-
ciations [56, 62, 68, 69] in the Chinese, Vietnamese and Czech
populations (n = 140–882). Two studies in Asian postmeno-
pausal women (n = 140; n = 260) reported significant associa-
tions with the ApaI variant (P = .036; P = .049, respectively)
[56, 68], where the study in the postmenopausal Vietnamese
women found that the ApaI risk allele ‘a’ had a 3 times in-
creased risk of overweight and obesity [56]. Hence, ApaI risk
allele may be an important factor predisposing individuals to
adult onset obesity among Asian postmenopausal women;
however, further large studies are warranted in men and women
to validate the role of the ApaI variant in this group.
TaqI SNP rs731236 Fourteen studies have examined the asso-
ciation between the VDR TaqI polymorphism and obesity
traits (Table 1), of which six have shown significant associa-
tion in several populations including Saudi, Czech, Greek,
French, and Chinese (n = 184–891) [54, 55, 61, 62, 65, 70].
In a case-control study in the Chinese Han population (n =
529), the TaqI polymorphism showed a strong association
with obesity (P < .001) [65] where the ‘t’ allele was 2.67 times
more prevalent in the obese group compared to the control
group and the ‘tt’ genotype showed a 3.79 times increased
risk of obesity. For the European andArab populations, results
have been largely inconsistent. Of the five studies in European
population (n = 184–123,865), three reported an association
between obesity traits and the TaqI polymorphism [61, 62,
70], while other studies failed to report a significant associa-
tion (n = 701–123,865) [23, 63]. Similarly, in the Arab
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population, two studies reported an association of the TaqI
polymorphism with obesity in Saudi individuals (n = 891;
n = 300) [54, 55], where the minor ‘t’ allele was significantly
more frequent in the obese group compared to the control
group (P = .009; P = .041, respectively). But, three other stud-
ies in Arabs from Saudi, Bahrain, and UAE (n = 198–570)
reported no significant association [37, 53, 60]. Although the
results are inconsistent and conflicting, given that the majority
of large studies failed to find an association, it is unlikely for
the TaqI polymorphism to have a significant impact on obe-
sity in Europeans and Arabs. However, due to existence of
genetic heterogeneity, the polymorphism may have an effect
on obesity in other ethnic groups such as Chinese population.
FokI SNP rs2228570 Twelve Studies have investigated the
association between the VDR FokI polymorphism and obesity
traits (Table 1) and only three of these have been consistent in
reporting a significant association in Caucasian men (n = 302)
and Czech (n = 517) and Chinese (n = 882) populations [62,
69, 71]. Studies in other ethnic groups such as Europeans,
Asians, and Arabs (n = 140–1,773) failed to find an associa-
tion of the FokI variant with obesity traits [53, 56, 58, 60, 61,
63, 65, 66, 72]. The overall evidence from these genetic epi-
demiological studies failed to support a consistent association
of this polymorphism with obesity traits.
Cdx2 SNP rs11568820 Three Studies have investigated the
association between the VDR Cdx2 SNP and obesity traits
(Table 1). Two of these studies reported significant associa-
tions between Cdx2 SNP and obesity and its related traits [66,
72]. A significant association of Cdx2 SNPwith waist circum-
ference (WC) and abdominal height (AH) (P = .03; P = .05,
respectively) was shown in a cross-sectional study in
American Caucasian women (n = 1,773) [72]; however, the
association did not remain significant after Bonferroni correc-
tion. On the other hand, a family-based study of 400 nuclear
Chinese families (n = 1,215) [66] reported significant associ-
ations of Cdx2 SNP with body mass index (BMI) (P = .046),
fat mass (FM) (P = .004) and PFM (P = .02). Furthermore, the
analysis in 415 sons showed that those with ‘AA’ genotype
had 5.4% higher BMI, 18.8% higher FM and 14.8% higher
PFM compared to those with ‘AG’ genotype. Nonetheless,
data from two large cohorts, the 1958 British Birth Cohort
(n = 5,224) and the GIANT Consortium (n = 123,865), failed
to find an association between the Cdx2 polymorphism and
obesity-related traits [23]. Even though the results are incon-
sistent regarding the effect of the VDR Cdx2 polymorphism
on obesity traits, majority of the large studies in Caucasians
have failed to find significant associations and hence this poly-
morphism is unlikely to have an impact among the Caucasian
population. However, such large studies in other ethnic groups
are required to confirm the role of this polymorphism in
obesity.
Other VDR SNPs Four studies have investigated other VDR
SNPs; of which, two have shown significant association [62,
72], while the other two failed to report a significant associa-
tion with obesity traits [23, 69]. A study in American
Caucasian women (n = 1,773) showed a significant associa-
tion of five VDR SNPs (rs739837, rs2239179, rs3819545,
rs3782905, and rs4760648) with obesity outcomes [72].
Another VDR SNP, EcoRV rs4516035 showed a significant
association with sum of skin fold thickness (SSFT) (P = .02),
where there was 7.7 times decrease in SSFT among those with
the ‘GG’ genotype compared to those with ‘AA’ genotype in
882 Czech individuals [62]. Given that the studies have been
conducted in small number of samples, large studies are re-
quired to further elucidate the role of these SNPs in obesity.
Type 2 Diabetes
BsmI SNP rs1544410 Twenty six studies have examined the
association between the VDR BsmI polymorphism and T2D
(Table 2), of which only seven have demonstrated a signifi-
cant association in Arab, Indian, Chinese and German popu-
lations (n = 80–627) [74–80]. The remaining fifteen studies
failed to show a significant association in populations of sim-
ilar ethnicities (n = 57–4,563) [53, 61, 81–93]. The meta-
analysis studies have also shown inconsistent findings, where,
of the four meta-analyses in Asian and Caucasian populations
(n = 2,608–6,274) [94–97], two of the studies (n = 4,578; n =
6,274) showed a marginal association between BsmI SNP and
risk of T2D (P = .033; P = .038, respectively) [95, 96]. Despite
several studies have been carried out in multiple ethnic
groups, the association between the VDR BsmI variant and
T2D is still questionable. It is possible that the effect of
gene-lifestyle interactions might mask the genetic effect in
some of the populations and hence studies focusing on gene-
diet and gene-physical activity interactions are required to
confirm this association.
ApaI SNP rs7975232 None of the fifteen studies have demon-
strated a significant association between ApaI polymorphism
and risk of T2D (n = 171–4,563) (Table 2) including the two
meta-analyses that investigated the association in up to 3,871
individuals [94, 95]. However, there was one study that re-
ported a borderline association (P = .058) in a Caucasian US
population (n = 1,545) [87]. Furthermore, a study in 171
Bangladeshi participants had shown a significant association
(P = .006) between ApaI SNP and insulin secretion index (ISI)
[84]. Based on these studies, it can be concluded that it is
unlikely that the VDR ApaI SNP has a significant role in the
development of T2D.
TaqI SNP rs731236 Despite twenty three studies have been
carried out to explore the association between VDR TaqI poly-
morphism and T2D (Table 2), only one small study has
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reported a significant association in the Indian population (n =
80) where ‘t’ allele had a 1.5 times increased risk of T2D [76].
Even the two large meta-analyses in Caucasians and Asians (n
up to 3,826) have failed to show an association [94, 95]. Given
that majority of the large studies failed to demonstrate a sig-
nificant association, the VDR TaqI SNP might not be a strong
candidate for T2D.
FokI SNP rs2228570 To date, eighteen studies have examined
the association between the VDR FokI SNP and T2D
(Table 2); five studies in the Saudi, Emirati, Egyptian and
the Chilean populations (n = 100–4,077) [53, 78, 81, 83, 85]
and three meta-analyses (n = 2,070–4,077) in Asians and
Caucasians [94–96] have reported significant associations.
Given that large meta-analysis studies have confirmed the
association of the SNP with T2D, the VDR FokI SNP might
have an important role to play in T2D among Asians and
Caucasians. Future meta-analyses should focus on other eth-
nic groups to identify the existence of genetic heterogeneity in
the association between VDR FokI SNP and T2D.
Cdx2 SNP rs11568820 Only two studies have examined the
association between the VDR Cdx2 SNP and T2D (Table 2);
one in the Italian population (n = 1,788) where individuals
with ‘AA’ genotype of the SNP had 1.43 times increased risk
of T2D compared to those with ‘GG + GA’ genotypes
(P = .002) [105] and the other one in the Norwegian popula-
tions (n = 4,563), which failed to show an association [93].
More studies in different ethnic groups are required to under-
stand the role of the VDR Cdx2 SNP in T2D.
BglI SNP rs739837 Of the four studies that examined the asso-
ciation between the VDR BglI polymorphism and T2D
(Table 2), two large case-control studies in the Chinese Han
population (n = 1,191 and n = 3,714) reported a significant
association of the BglI polymorphism with increased risk of
T2D [92, 104]. However, there was no association between
the BglI variant and risk of T2D in a smaller study in the
Chinese Han (n = 420) and Chinese Hui (n = 269) populations
[79] as well as no association was observed in the Caucasian
population (1958 British Birth Cohort, n = 5,160) [73]. This
inconsistency can be attributed to the sample size and the
existence of genetic heterogeneity between the Caucasian
and Chinese ethnic groups; but additional large studies are
warranted to confirm or refute these findings.
Other VDR SNPs A few studies have investigated other SNPs
in the VDR gene; three studies reported a significant associa-
tion of the VDR SNPs, rs2239179, rs7968585, rs2189480 and
rs3847987, with T2D risk [92, 93, 106]. The two VDR SNPs,
rs2189480 and rs3847987, were reported to have significant
association (P = < 0.003 and P = .032, respectively) with T2D
in a Chinese Henan population (n = 574) [106]. The VDR SNP
rs2239179 was found to be significantly associated with in-
creased risk of T2D (P = .049) in Chinese Han men who were
above 55 years (n = 1,191) [92] and the VDR SNP rs7968585
showed a significant association with T2D (P = .044) in the
Norwegian population (n = 4,563) [93]. These SNPs might
have a functional importance in the pathogenesis of T2D,
which needs to be further investigated and evaluated by
large-scale studies in different populations.
Conclusions
In summary, our review has pooled all available data related to
the association of vitamin D pathway genes with metabolic
diseases such as obesity and T2D and has identified 57 signif-
icant associations of vitamin D pathway genes with obesity
and its related traits such as BMI, WC, FM, SSFT, and AH in
SNPs from 5 genes in the vitamin D pathway. Of the 57
associations, only one was from the vitamin D synthesis-
related genes (DHCR7, CYP2R1). The vast majority of the
associations (56 associations) were identified in the vitamin
Dmetabolism-related genes (CYP24A1, GC and VDR) and, in
particular, the VDR gene SNPs showed 48 significant associ-
ations with obesity outcomes. In addition, our review has
identified 35 significant associations in relation to T2D in
SNPs from 7 genes in the vitamin D pathway. A similar pat-
tern of association was seen where only five significant asso-
ciations were reported for vitamin D synthesis-related genes
(DHCR7 and CYP2R1) as compared to the vitamin D
metabolism-related genes (CYP24A1, GC and VDR), where
30 significant associations were observed, and, in particular,
26 significant associations with T2D was seen for the VDR
SNPs.
The vitamin D synthesis-related genes, DHCR7 and
CYP2R1, have not been adequately investigated in relation
to obesity and T2D. There is a gap in the research pertaining
to the effect of vitamin D synthesis-related gene polymor-
phisms on obesity and T2D. For vitamin D metabolism-
related genes, the literature is still lacking in several ethnic
groups, and available results are inconsistent. Understanding
how genetics influence serum 25(OH)D levels is important for
identifying persons at risk of vitamin D deficiency and im-
proving the understanding of the observed association be-
tween vitamin D deficiency and several diseases. Large
well-designed genetic association studies considering gene-
environment interactions in multiple ethnic populations are
necessary to improve the understanding of the role of vitamin
D-related polymorphisms in metabolic diseases. Furthermore,
functional characterization of the vitamin D-related SNPs is
highly warranted to facilitate the understanding of the patho-
genetic mechanisms of obesity and diabetes, which will pro-
vide the platform for developing strategies to prevent and treat
metabolic diseases.
J Diabetes Metab Disord
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